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Recently, by using a combination of two viral vectors, we developed a technique
for pathway-selective and reversible synaptic transmission blockade, and successfully
induced a behavioral deficit of dexterous hand movements in macaque monkeys by
affecting a population of spinal interneurons. To explore the capacity of this technique
to work in other pathways and species, and to obtain fundamental methodological
information, we tried to block the crossed tecto-reticular pathway, which is known to
control orienting responses to visual targets, in mice. A neuron-specific retrograde gene
transfer vector with the gene encoding enhanced tetanus neurotoxin (eTeNT) tagged with
enhanced green fluorescent protein (EGFP) under the control of a tetracycline responsive
element was injected into the left medial pontine reticular formation. 7–17 days later,
an adeno-associated viral vector with a highly efficient Tet-ON sequence, rtTAV16, was
injected into the right superior colliculus. 5–9 weeks later, the daily administration of
doxycycline (Dox) was initiated. Visual orienting responses toward the left side were
impaired 1–4 days after Dox administration. Anti-GFP immunohistochemistry revealed
that a number of neurons in the intermediate and deep layers of the right superior
colliculus were positively stained, indicating eTeNT expression. After the termination of
Dox administration, the anti-GFP staining returned to the baseline level within 28 days.
A second round of Dox administration, starting from 28 days after the termination of the
first Dox administration, resulted in the reappearance of the behavioral impairment. These
findings showed that pathway-selective and reversible blockade of synaptic transmission
also causes behavioral effects in rodents, and that the crossed tecto-reticular pathway
clearly controls visual orienting behaviors.
Keywords: superior colliculus, pontine reticular formation, orienting behavior, viral vector, Tet-ON, tetanus
neurotoxin, mouse
INTRODUCTION
To study structure-function relationships within neural circuits,
it is necessary to manipulate the activity of an “identified” pop-
ulation of neuronal elements in these circuits. Recent advances
in molecular genetic techniques enabled such targeted manipula-
tion by making transgenic animals with cell-specific promoters
(Kobayashi et al., 1995; Watanabe et al., 1998). However, such
techniques have generally been constrained to those animals in
which the transgenic manipulation of gene expression is possi-
ble (i.e., mouse, nematode, Drosophila, etc.) and to neuron types
whose cell-specific promoter has been identified. An alternative
possibility is to use viral vectors to introduce particular genes. To
enable pathway specificity, lentivirus vectors pseudotyped with
rabies virus glycoprotein (RVG) were developed as vectors spe-
cific for retrograde transport (Kato et al., 2007). However, such
vectors were not sufficiently efficient to affect enough of a specific
neuron population to induce behavioral effects, especially in
larger animals such as non-human primates. To overcome such
difficulties, Kobayashi and colleagues recently enhanced the ret-
rograde transport efficiency of lentivirus vectors by pseudotyping
with a chimera of rabies virus and vesicular stomatitis virus
glycoprotein (VSVG) [highly efficient retrograde gene transfer
(HiRet) vector; Kato et al., 2011a]. We incorporated a tetracy-
cline responsive element (TRE) and enhanced tetanus neurotoxin
(eTeNT) tagged with enhanced green fluorescent protein (EGFP)
into this retrograde vector (HiRet-TRE-EGFP.eTeNT). We also
incorporated the newly developed efficient Tet-ON sequence
rtTAV16 into an adeno-associated type 2 virus vector (AAV-2)
with a cytomegalovirus promoter (CMV) (AAV2-CMV-rtTAV16)
(Kinoshita et al., 2012) as a switch to regulate the first con-
struct. To study the function of a subpopulation of propriospinal
neurons (PNs) whose cell bodies are located in the mid-cervical
segments and project to hand/arm motor neurons in macaque
monkeys, we injected HiRet-TRE-EGFP.eTeNT into the ventral
horn of the C6–Th1 segments; one week later, we injected AAV2-
CMV-rtTAV16 into the intermediate zone of the C2–C5 segments
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where the PN cell bodies are located. 1–2 months later, we initi-
ated the administration of doxycycline (Dox). We could observe
deficits in reach and grasp movements. Acute electrophysiological
experiments clarified that approximately 90% of the transmis-
sion through the PNs was blocked. Theoretically, this method
should be available for universal use in the various pathways of the
central nervous system without the need to identify cell-specific
promoters or develop genetically modified animals.
At the current stage, we still need to know the fundamen-
tal properties of this technique and how to optimize it. For this
purpose, however, non-human primates are not the best ani-
mal species because the number of available animals is limited,
and behavioral and histological analyses are time consuming.
Therefore, we decided to use mice to establish the fundamen-
tal protocol of this technique. Moreover, we wished to select
a pathway whose function is easy to investigate using behav-
ioral observations. We chose the crossed tectoreticular pathway
(cTRNs), which originates from the intermediate and deep lay-
ers of the midbrain superior colliculus (SC) and terminates in
the medial pontomedullary reticular formation contralateral to
the SC (Grantyn and Berthoz, 1987; Redgrave et al., 1990; Isa
and Sasaki, 2002; Sooksawate et al., 2005, 2008). This pathway
is known to control the orienting response of the eyes, head,
and body to visual targets (Wurtz and Albano, 1980; Sparks,
1986; Dean et al., 1989; Isa and Sasaki, 2002; Isa and Hall, 2009),
which is an innate behavior that does not require training. In
this study, we focused on the time course of the effect of pathway
blockade through behavioral and histological examinations after
starting Dox administration and after its offset. We also tested the
reversibility of the effects by halting and repeating Dox admin-
istration. This technique proved very feasible in mice, suggesting
that it could be used universally as a relatively convenient method
for the pathway-specific manipulation of neural activity and gene
expression.
MATERIALS AND METHODS
The animal experimental procedures in this study were conducted
in accordance with the Guidelines of the National Institutes of
Health and the Ministry of Education, Culture, Sports, Science,
and Technology of Japan, and were approved by the Institutional
Animal Care and Use Committee of the National Institutes of
Natural Sciences. All attempts were made to minimize the suf-
fering and number of animals used in this study. The methods
and time schedule of the present experiments are summarized in
Figure 1.
PREPARATION OF VIRAL VECTORS
Vector preparation was described by Kinoshita et al. (2012).
However, a major difference was that we used a neuron-specific
highly efficient retrograde gene transfer lentivirus (NeuRet) vec-
tor (Kato et al., 2011b) instead of the HiRet vector, because the
NeuRet vector is specifically taken up by axons at the injection
site.
NeuRet-TRE-EGFP.eTeNT
TheNeuRet vector is a pseudotype of a human immunodeficiency
virus type 1-based lentiviral vector with fusion glycoprotein
type C. In previous studies, it has been shown that pseudotyp-
ing the lentiviral vector with the RVG changed the property of
the vector specific for retrograde gene transfer (Kato et al., 2007).
However, the efficiency of the gene transfer was not enough
to affect the majority of neurons projecting to the injection
site. Later, it was found that replacing RVG with a chimeric
protein of RVG and VSVG domains greatly enhanced the effi-
ciency of retrograde gene transfer (highly efficient retrograde gene
transfer vector or HiRet vector) (Kato et al., 2011a). Then, the
use of a different chimeric protein composing RVG and VSVG
(fusion glycoprotein type C) switched the properties to neuron-
specific infection (NeuRet) (Figure 1A; Kato et al., 2011b). In the
present study, the envelope plasmid encoding fusion glycopro-
tein type C, which was under the control of the cytomegalovirus
(CMV) enhancer/chicken β-actin promoter, was used for vec-
tor production. Chimeric EGFP.eTeNT.PEST was generated by
fusing the human codon-optimized tetanus neurotoxin light
chain (eTeNT) with the EGFP derived from pEGFP-N1 vector
(Clontech, Mountain View, CA, USA) and the PEST sequence of
ornithine decarboxylase, as reported previously (Kinoshita et al.,
2012). The transfer plasmid pLV-TRE-EGFP.eTeNT.PEST was
based on pFUGW (a gift from D. Baltimore, California Institute
of Technology, Pasadena, CA, USA), and constructed by swap-
ping the ubiquitin promoter-EGFP sequence with the TRE/CMV
promoter of the pTRE-Tight vector (Clontech, Mountain View,
CA, USA) and EGFP.eTeNT.PEST. The NeuRet vector encod-
ing EGFP.eTeNT was placed downstream of the TRE pro-
moter (termed NeuRet-TRE-EGFP.eTeNT) and was prepared as
described previously (Inoue et al., 2012).
AAV2-CMV-rtTAV16
The rtTA variant rtTAV16 was generated by introducing the
V9I, G12S, F67S, F86Y, R171K, and A209T mutations into
rtTA2S-M2 of the pTet-ON advanced vector (Clontech,Mountain
View, CA, USA), as reported previously (Kinoshita et al., 2012).
Plasmid pAAV2-CMV-rtTAV16 (Figure 1A) is based on pAAV-
MCS (Agilent Technologies, Inc., Santa Clare, CA, USA), and
was constructed by inserting the CMV promoter sequence of
the pTet-On advanced vector rtTAV16, the woodchuck hepatitis
virus posttranscriptional regulatory element WPRE sequence of
pFUGW, and the SV40 polyadenylation signal (SV40pA) of the
pCMV-script vector (Agilent Technologies, Tokyo, Japan) into a
multiple cloning site. The AAV vector for in vivo injection was
produced as described previously (Kaneda et al., 2011).
INJECTIONS OF NeuRet-TRE-EGFP.eTeNT AND AAV2-CMV-rtTAV16
We anesthetized 6–10-week-old male C57BL/6 mice with an
intraperitoneal injection of a mixture of ketamine (60mg/kg
body weight) and xylazine (10mg/kg body weight). In addition,
dexamethasone (5.5mg/kg body weight) was injected intramus-
cularly as premedication. The head of the mouse was fixed to the
stereotaxic apparatus (Narishige, Tokyo, Japan) and injections of
the vectors were made from the dorsal approach. NeuRet-TRE-
EGFP.eTeNT (0.8–1.2μL); titer, 3.3–12.1 × 1011 copies/mL) was
injected into the medial pontine reticular formation (MPRF)
on the left side (Figures 1B,C) using a thin glass micropipette
(tip diameter, 50–70μm) inclined by 45◦caudally to the vertical
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FIGURE 1 | Experimental protocols for the selective blockade of the
crossed tectoreticular pathway by double infection with the NeuRet
lentiviral vector (carrying EGFP.eTeNT) and the AAV2 vector (carrying the
Tet-ON sequence, CMV-rtTAV16). (A) The design of the two viral vectors.
(B) Photomicrographs of the superior colliculus (SC) and medial pontine
reticular formation (MPRF) showing the viral vector injection targets. (C)
Diagram for the double injection of the viral vectors into the MPRF and SC,
and the interaction of NeuRet-TRE-EGFP.eTeNT and AAV2-CMV-rtTAV16 in
the double infected crossed tectoreticular neurons (cTRNs). (D) The
experimental schedule of this study.
axis of the stereotaxic coordinates (Franklin and Paxinos, 2008),
−8.3mm from the bregma, 0.7mm lateral to the midline, and
at 3.6 and 4.4mm from the presumed dorsal surface of the cere-
bellar cortex (0.4–0.6μL/point of injection). 7–17 days after the
NeuRet-TRE-EGFP.eTeNT injection, AAV2-CMV-rtTAV16 (0.8–
1.0μL; titer, 1.96 × 1013 particles/mL) was injected into the SC
on the right side (Figures 1B,C). A small hole was made in the
skull over the occipital cortex and a thin glass micropipette (tip
diameter; 50–70μm) was inserted vertically into the right SC,
−4.0 to −4.2mm from the bregma, 1.1–1.2mm lateral to the
midline, and at 1.1–1.6 and 1.4–2.3mm from the presumed dor-
sal surface of the cerebral cortex (0.4–0.5μL/point of injection).
We used a syringe pump (ESP-32; Eicom, Kyoto, Japan) for the
injection; the injection rate was 0.1μL/min. Before removing the
glass micropipette from the injection site, we waited for 5min.
The transfer plasmid pLV-TRE-EGFP.eTeNT.PEST is switched
on to produce the tetanus neurotoxin only when the rtTAV16
sequence provided by the AAV2-CMV-rtTAV16 vector is
expressed in the same neuron and activated by Dox (Figure 1C).
The tetanus neurotoxin blocks the transmitter release by cleav-
ing VAMP-2 at the nerve terminals, but does not kill the cell (for
review see Montecucco and Schiavo, 1994).
DOX ADMINISTRATION
5–9 weeks after the injection of AAV2-CMV-rtTAV16, the daily
administration of Dox was initiated by a single intraperi-
toneal injection (10μg/g body weight) of Dox in a 0.9% NaCl
solution, followed by the continuous oral administration of
Dox in the drinking water (3mg/mL in a 5% sucrose solu-
tion) for 7 days (Figure 1D). In some animals, the second
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period of Dox administration (2nd Dox administration) was
conducted from 28 days after the offset of the first period
of Dox administration (1st Dox administration). One group
of mice received Dox continually for 21 days for histological
analysis.
BEHAVIORAL TESTS FOR VISUAL ORIENTING AND TURNING BEHAVIOR
We utilized three tests to assess visual orienting and turning
behaviors: (1) the visual placing response, (2) the visual orienting
response, and (3) a turning behavior test (Figure 1D). The behav-
ioral tests began on the day before Dox administration, continued
during Dox administration for 7 days, and after Dox administra-
tion for 7 days. All tests were performed between 6.00 AM and
3.00 PM.
Visual placing response
Amodified visual placing response test was used to evaluate visual
orienting behavior toward the affected and unaffected sides of
the tested mouse. This test was modified from Metz and Schwab
(2004) and Pinto and Enroth-Cugell (2000). In this test, the
mouse was suspended by holding its tail and then lowered toward
a plastic plate either on the left or right side of the head with-
out any contact to the vibrissae. Normally, when the head of
a mouse was lowered to near the edge of the plastic plate, it
turned its head and trunk, and extended its forelimbs to place
them on the plate (see Figure 2A). The procedure was conducted
bilaterally (10 trials per side each day). The number of times
the mouse successfully placed its forelimbs on the plate was
counted.
Visual orienting response
A visual orienting response test was used to evaluate visual ori-
enting behavior toward a visual target presented either on the
affected or unaffected side of the tested mouse. The mouse was
placed inside a small glass cylinder (15 cm height, 14 cm inner
diameter), and a stimulus (a small long-handle stainless steel
chemical spoon) was quickly moved into the visual field of the
mouse from behind, in the same horizontal plane as its eyes, until
the stimulus was located between its eyes (Smith et al., 1998).
Normally, when the stimulus entered its visual field, the mouse
turned its head toward the stimulus (Figure 3A). The procedure
was conducted bilaterally in a pseudorandom sequence (10 trials
FIGURE 2 | (A) Series of photographs showing the effect of the
Tet-induced tetanus neurotoxin-expressing system on the visual placing
response toward the affected side (Dox-on day 3) and disappearance of the
effect (Dox-on day 6), compared with the unaffected side. (B) Effect of the
Tet-induced tetanus neurotoxin-expressing system on the visual placing
response toward the affected side after the 1st Dox administration for 7
days, termination of Dox administration for 28 days, and the 2nd Dox
administration for 7 days.
FIGURE 3 | (A) A photograph showing the visual orienting response of
a mouse toward the unaffected side. (B) Effect of the Tet-induced
tetanus neurotoxin-expressing system on the visual orienting response
of the affected side after the 1st Dox administration for 7 days,
termination of Dox administration for 28 days, and the 2nd Dox
administration for 7 days.
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per side each day). The number of times the mouse successfully
oriented itself to the stimulus was counted.
Turning behavior
A turning behavior test was used to evaluate the effect of the Tet-
induced tetanus neurotoxin-expressing system on the preferred
side of turning of the tested mouse after Dox administration. The
mouse was placed into a small glass cylinder (15 cm height, 14 cm
inner diameter), which forced it to turn left or right inside the
cylinder (Figure 4A). The number of complete turns (360◦) to
each side was recorded for 10min each day.
IMMUNOHISTOCHEMICAL ASSESSMENTS
At the end of the experiments, the mice were deeply anes-
thetized with an intraperitoneal injection of sodium pentobarbi-
tal (80mg/kg body weight) (Hospira Inc., Lake Forest, IL, USA)
and transcardially perfused with 0.05M phosphate-buffered
saline and then 4% paraformaldehyde in a 0.1M phosphate buffer
(pH 7.4). The brainstem and spinal cord were cryoprotected and
sectioned at a thickness of 40μm using a sliding microtome (HM
450; Microm, Walldorf, Germany). To obtain a clearer image of
the cell bodies, dendrites and axons of the double infected neu-
rons, we adopted permanent visualization of EGFP-positive cells
with anti-GFP immunohistochemistry. In particular, the perma-
nent visualization technique made the axon tracing much easier.
Moreover, the distribution of neurons infected by AAV2-CMV-
rtTAV16 was assessed with in situ hybridization to detect the
rtTA sequence (the antisense probe for the tetracycline transac-
tivator, tTA, was a gift from T. Yamamori, National Institute for
Basic Biology, Okazaki, Japan). The technical details of the anti-
GFP immunohistochemistry and in situ hybridization against the
rtTAV16 sequence were described previously (Kinoshita et al.,
2012) and are available on the web (http://www.nibb.ac.jp/brish/
indexE.html), respectively. The number of GFP-positive neu-
rons and tracings of the axons originating from their cell bodies
to their target areas were counted and drawn using a camera
lucida attached to a light microscope (BX51; Olympus, Tokyo,
Japan). Photomicrographs of the histological slices were taken
using light microscopes (Axioplan2; Zeiss, Göttingen, Germany
and BZ-9000; Keyence, Elmwood Park, NJ, USA).
DATA ANALYSIS
Data are expressed as the mean ± standard error of the mean.
Significance was tested by Student’s t-test, and a P value of less
than 0.05 was considered to be significant.
RESULTS
A total of 61 C57BL/6 mice were used in this study; the two
viral vectors were injected into 56 mice. As controls, some
mice received an injection of NeuRet-TRE-EGFP.eTeNT with-
out Dox administration (n = 2), NeuRet-TRE-EGFP.eTeNT and
AAV2-CMV-rtTAV16 without Dox administration (n = 2), or
NeuRet-TRE-EGFP.eTeNT with Dox administration (n = 3), and
one group of mice was not injected (n = 5). No clear behav-
ioral effects could be observed in any of these control groups.
Specifically, the % success rate for the visual placing response
on the side contralateral to the collicular injection ranged from
95.00 ± 5.00 to 100.0 ± 0.00%, which was not significantly dif-
ferent from the side ipsilateral to the collicular injection (100.0 ±
0.00%). The % success rate for the visual orienting responses
on the side contralateral to the collicular injection ranged from
95.00 ± 5.00 to 100.0 ± 0.00%, which was also not significantly
different from the side ipsilateral to the collicular injection that
ranged from 95.00 ± 5.00 to 100.0 ± 0.00%. Moreover, the %
turning rate to the side contralateral to the collicular injection was
not significantly different from the side ipsilateral to the collicu-
lar injection on any of the testing days (Dox-on day 0 to Dox-on
day 7). It ranged from 44.60 ± 5.63 to 50.40 ± 3.15%.
BEHAVIORAL OBSERVATIONS
Visual placing response
After Dox administration, the visual placing response toward the
affected side (left side) of the double infected mice was impaired
from Dox-on day 1 to day 5, with the maximal impairment on
Dox-on day 3 compared with the unaffected side (right side).
The mice failed to turn their head and trunk and place their
forelimbs onto the plastic plate when they were lowered with
the plastic plate on the affected side (Figure 2A). The % success
rate for placing toward the affected side was reduced to 58.95 ±
5.41%, compared with 99.47 ± 0.3671% for the unaffected side
FIGURE 4 | (A) A photograph showing the turning behavior of a mouse to the unaffected side (right). (B) Effect of the Tet-induced tetanus neurotoxin-expressing
system on turning behavior after the 1st Dox administration for 7 days, termination of Dox administration for 28 days, and the 2nd Dox administration for 7 days.
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(P< 0.0001, n = 38, unpaired t-test; Figure 2B). However, this
behavioral effect was gradually reduced from Dox-on day 4 and
completely disappeared on Dox-on days 6–7. After the termi-
nation of Dox administration, no behavioral effect could be
seen on the affected and unaffected sides for 7 days (Dox-off
days −1 to −7).
Visual orienting response
Impairment of the orienting response could also be found in
the visual orienting response test. After Dox administration, the
visual orienting response toward the affected side (left side) was
impaired from days 1–6, while it was not impaired toward the
unaffected side (right side) (Figure 3A). The % success rate of
the affected side was reduced to 64.21 ± 4.473%, compared to
the 96.32 ± 0.793% of the unaffected side (P < 0.001, n = 38,
unpaired t-test; Figure 3B). The behavioral effect was gradu-
ally reduced from Dox-on day 4, and completely disappeared by
Dox-on day 7. After the termination of Dox administration, no
behavioral effect could be seen on the affected and unaffected
sides for 7 days (Dox-off days −1 to −7).
Turning behavior
Before Dox administration and in the control groups, the mice
almost equally preferred to turn toward the left and right.
However, after Dox administration, the mice preferred to turn
to the unaffected side (right) (Figure 4A). The % turning to the
affected side (left side) was reduced from Dox-on days 1 to 4,
with the maximal reduction on day 3 (Figure 4B). The % turn-
ing to the affected side was reduced to 23.92 ± 2.721% from the
42.77 ± 1.824% of the controls on day 0 (P < 0.001, n = 38,
unpaired t-test). Then, the % turning to the affected side grad-
ually returned to the same level as before Dox administration
by Dox-on day 7. It is noteworthy that after the termination of
Dox administration, % turning to the affected side (left side)
increased to its highest level on Dox-off day −2 (P < 0.05, n =
15, unpaired t-test), before returning to the same level as before
Dox administration on Dox-off days −5 to −7.
REVERSIBILITY OF THE DOX-ON EFFECTS
28 days after the termination of the 1st Dox administration (for
7 days), the 2nd Dox administration was started for another 7
days. All of the behavioral tests for visual orienting were found
to be impaired after the 2nd Dox administration. The pattern
and time course of the impairments were almost the same as
for the 1st Dox administration. The % success rates for the
visual placing response (Figure 2B) and visual orienting response
(Figure 3B) and % turning (Figure 4B) toward the affected side
were reduced on Dox-on days 1–2 to days 4–5 and, then, grad-
ually increased to the same levels as before Dox administration
on days 6–7. Although, the maximal effects of the 2nd Dox
administration on all behavioral tests appeared to be greater,
they were not significantly different from the 1st Dox admin-
istration (visual placing response, P = 0.0531; visual orienting
response, P = 0.2123; turning behavior, P = 0.1544, unpaired
t-test). These results indicate that the selective blockade of the
crossed tectoreticular pathway by double infection with NeuRet-
TRE-EGFP.eTeNT and AAV2-CMV-rtTAV16 can be performed
repeatedly with an interval of 28 days.
HISTOLOGICAL ANALYSIS
The number of GFP-positive crossed tectoreticular neurons
(cTRNs) in the intermediate and deep layers of the SC of the
double infected mice increased sharply after the start of Dox
administration for 1 day and reached its maximum on Dox-on
day 3 (Figures 5A,C). The maximum number of GFP-positive
cTRNs was 458.8 ± 141.4 neurons (n = 6). After Dox adminis-
tration was terminated, the number of GFP-positive cTRNs was
gradually reduced on Dox-off days −3 to −14, and had returned
to the baseline level by Dox-off day −28. To confirm the injec-
tion site of AAV2 in the right SC, in situ hybridization of rtTAV16
was performed. The injection sites were found to be located in
the intermediate to deep layers of the right SC (Figure 5B). To
demonstrate the reversibility of the Dox-on effects in these dou-
bled infected mice, the 2nd Dox administration was started after
a 28-day Dox-off period. The number of GFP-positive cTRNs in
the intermediate and deep layers of the right SC increased again
to 400.0 ± 218.3 (n = 3; Figure 5C). The histological results par-
alleled the impairment of visual orienting behavior after the 2nd
Dox treatment in this group (Figures 2B, 3B, 4B).
In another group of mice (n = 3), the period of Dox adminis-
tration was extended to 21 days, which resulted in strong staining
of the cTRNs with anti-GFP immunohistochemistry that filled
their distal dendrites. The axons from their cell bodies in the
intermediate and deep layers of the right SC (Figure 6A) were
labeled all the way to their target areas. Such tracing was diffi-
cult to perform in the mice with Dox administration for 7 days.
The axons and terminals (Figures 6B,C) of these GFP-positive
cTRNs could be found in the right mesodiencephalic junction
[e.g., fields of Forel (FF), zona incerta (ZID, ZIV)] (Figure 6Ca),
mesencephalic reticular formation (mRt) (Figure 6Cb), nucleus
reticularis tegmenti pontis (RtTg) (Figures 6Cc,d), pontine retic-
ular formation (PRF; including the injection site of NeuRet-TRE-
EGFP.eTeNT) (Figures 6Cc,d,e), gigantocellular reticular nucleus
(Gi) (Figure 6Ce), inferior olivary nuclei (IO) (Figure 6Cf), etc.
Thus, in addition to the injection site of the NeuRet vector, posi-
tive axons and terminals were found in many other target areas of
collaterals that originated from the cTRNs (see Discussion).
TIME COURSE OF THE DOX-ON AND DOX-OFF PERIODS
To compare the time course of the behavioral effects and the
appearance of anti-GFP immunoreactivity in cTRNs for the
Dox-on and Dox-off periods, the results of the three behav-
ioral tests were normalized to the maximal impairment and
averaged. Then, the normalized values were compared to the
normalized number of GFP-positive cTRNs during the Dox-on
and Dox-off periods (Figure 7). The number of GFP-positive
cTRNs increased sharply after the administration of Dox for
1 day, reached its maximum on Dox-on day 3, and was
maintained until the end of Dox administration on day 7.
Although behavioral impairment was also found from Dox-
on day 1, it increased slower than the appearance of GFP-
positive cTRNs. In contrast to the number of GFP-positive
cTRNs, the behavioral impairment, after reaching its maxi-
mal effect on Dox-on day 3, was reduced to near the baseline
level on Dox-on days 6–7. After Dox administration was ter-
minated on day 7, the number of GFP-positive cTRNs was
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FIGURE 5 | Photomicrographs of GFP-positive cTRNs and in situ
hybridization to visualize rtTAV16 in the superior colliculus (SC) of
double infected mice. (A) Schematic diagram of the laminar structure of the
mouse SC (frontal plane) and photomicrographs of the SC slices processed
with anti-GFP immunohistochemistry (frontal section, inset area in the SC
diagram), before Dox administration (Dox-on day 0), Dox administration for 1
day (Dox-on day 1), 3 days (Dox-on day 3), 7 days (Dox-on day 7), and after the
termination of Dox administration for 3 days (Dox-off day −3), 7 days
(Dox-off day −7), 14 days (Dox-off day −14), and 28 days (Dox-off day −28).
(B) In situ hybridization against the tTA sequence in an SC slice indicating the
cells infected by AAV2. (C) Average number of GFP-positive neurons in the
SC after the 1st Dox administration for 7 days, termination of Dox
administration for 28 days, and after the 2nd Dox treatment for 7 days (n = 3).
Abbreviations: SGS, superficial gray layer; SO, optic layer; SGI, intermediate
gray layer; SAI, intermediate white layer; SGP, deep gray layer; SAP, deep
white layer; PAG, periaqueductal gray.
gradually reduced and reached the baseline level on Dox-off
day −28.
DISCUSSION
The crossed tectoreticular pathway has been suggested to be
involved in the control of orienting responses based on the fol-
lowing evidence: (1) repetitive electrical stimulation of the SC
induces contraversive orienting responses (Cowie and Robinson,
1994; Corneil et al., 2002) and that of the medial pon-
tomedullary reticular formation induces ipsiversive orienting
responses (Cowie and Robinson, 1994); (2) lesion or reversible
inactivation of the SC (Rosenquist et al., 1996; Quaia et al., 1998)
or medial pontomedullary reticular formation (Isa and Sasaki,
1988) impairs orienting responses; (3) single unit recordings
either from the SC (Sparks, 1975, 1978) or the medial pon-
tomedullary reticular formation (Grantyn and Berthoz, 1987;
Isa and Naito, 1995; Isa and Sasaki, 2002) reveal the existence
of neurons that show increased firing preceding the orienting
response; and (4) anatomically, the medial pontomedullary retic-
ular formation receives massive inputs from the intermediate and
deep layers of the contralateral SC (Kawamura and Brodal, 1973;
Huerta and Harting, 1982). Thus, there is overwhelming evidence
that the tectoreticular pathway plays a major role in the con-
trol of orienting responses (Sparks, 1986; Isa and Sasaki, 2002).
However, the specific role of cTRNs in gaze has been difficult
to resolve. In fact, this difficulty in precisely attributing function
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FIGURE 6 | Tracings of the axonal trajectories of the GFP-positive
cTRNs in the superior colliculus (SC) in the mice with Dox treatment
for 21 days. (A) GFP-positive cTRNs in the right SC. (B) Axon terminals
(arrows) in the left pontine reticular formation. (C) Tracings of the axons
and their terminals in the brainstem: a. Pretectum; b. Midbrain (SC level);
c. Midbrain (inferior colliculus level); d. Pons (rostral part); e. Pons (caudal
part); f. Medulla. GFP-positive cell bodies are indicated as blue dots in Cb.
Abbreviations: 5N, trigeminal nucleus; 7N, facial nucleus; 7n, facial nerve;
12N, hypoglossal nucleus; CnF, cuneiform nucleus; cp, cerebral peduncle;
FF, fields of Forel; fr, fasciculus retroflexus; g7, genu of the facial nerve; Gi,
gigantocellular reticular nucleus; IC, inferior colliculus; IO, inferior olive; mlf,
medial longitudinal fasciculus; mRt, mesencephalic reticular formation;
PAG, periaqueductal gray; pc, posterior commissure; PRF, pontine reticular
formation; py, pyramidal tract; RMg, raphe magnus nucleus; RN, red
nucleus; rs, rubrospinal tract; RtTg, nucleus reticularis tegmenti pontis;
SAI, intermediate white layer; SAP, deep white layer; scp, superior
cerebellar peduncle; SGI, intermediate gray layer; SGP, deep gray layer;
SGS, superficial gray layer; SO, optic layer; SNr, substantia nigra pars
reticulata; sp5, spinal trigeminal tract; ZID, zona incerta, dorsal part; ZIV,
zona incerta, ventral part.
to a specific cell population exists for many of the neural sys-
tems in the brain. In this regard, the present study, for the first
time, showed that pathway-specific and reversible blockade of
synaptic transmission worked as efficiently to cause behavioral
deficits in mice, as it has in non-human primates (Kinoshita et al.,
2012). Moreover, it specifically provides clear evidence that the
direct crossed tectoreticular pathway is essential for the execu-
tion of orienting responses. Previous pharmacological techniques
were not able to dissect this pathway from other tectal output
pathways, such as the thalamic projection from the superficial
layer, which might be involved in the higher visual processing
(May, 2006), and from the uncrossed tecto-reticular pathway,
which has been reported to control the avoidance behaviors
(Sahibzada et al., 1986; Dean et al., 1989). However, the present
method will enable us to pin down the functions of these indi-
vidual components of the output pathways from the SC in near
future.
Finally, we analyzed the methodological details of this
technique, especially the time course of the effects of Dox-on
and Dox-off with this relatively simple behavioral system. These
experiments made use of a fair number of mice, which would be
difficult to perform in non-human primates.
TIME COURSE AFTER DOX-ON
In this study, the behavioral effects of Dox administration could
be partially observed as early as 24 h after initiation. This is
earlier than observed in our previous study on macaque mon-
keys, in which the effects appeared on the 2nd day. This may be
partly because we used an intraperitoneal injection on the first
day to facilitate the quick onset of the effects (Perl et al., 2002).
However, a species-related difference cannot be excluded. The
effects became maximal on the 2nd and 3rd days after initiation,
but gradually became smaller and had mostly disappeared by the
6th day. It is clear that this is not due to the disappearance of
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FIGURE 7 | Schematic drawing of the time course for the emergence
and disappearance of blocking effects as measured by the behavioral
effects and detectability of anti-GFP immunoreactivity after the onset
and offset of Dox administration.
the Dox effects on the tetanus toxin production in the doubly
infected neurons because the number of GFP-positive cells did
not parallel the disappearance of the behavioral effects rather it
persisted, as long as Dox was administered continuously. Such a
disappearance of the behavioral effects must instead be caused
by a compensatory mechanism in the residual pathways. This
assumption is partly supported by the observation of a contralat-
eral postural deviation in the turning response at 2 days after
Dox-off (Figure 4). It is not clear which neural systems were
responsible for such compensation, but it is likely due either to
cTRNs, which were spared from double infection by vectors, or
to direct corticoreticular pathways or to other unknown pathways
involved in the control of visual orienting responses. A combina-
tion of these must have taken over the function of the blocked
neurons.
TIME COURSE AFTER DOX-OFF
In this study, the behavioral changes were mostly not observed
after Dox-offset following 7 days of Dox administration. We
noticed a postural deviation to the right side at 2 days after Dox-
off, which might be due to a compensatory mechanism estab-
lished during the Dox-on period. Histological analysis showed
that the number of GFP-positive cells gradually decreased after
Dox-off, and returned to the baseline level on the 28th day after
Dox-off. Furthermore, the 2nd Dox application on the 28th day
after Dox-off caused as potent behavioral effects as during the
1st Dox administration. At least a one-month interval was nec-
essary to observe the reversibility of the Dox effect. Since the
functional compensation for the loss of transmission through a
population of cTRNs may be caused by other compensatory neu-
ral circuits, this reversibility suggests that the mouse brain reused
the cTRNs that had been blocked, once their transmission was
restarted.
BLOCKADE OF TRANSMISSION THROUGH OTHER COLLATERALS OF
THE cTRNs
Our previous study in macaque monkeys (Kinoshita et al., 2012)
showed that anti-GFP immunohistochemistry clarified not only
the location of the cell bodies of the PNs that expressed EGFP,
but also their axonal trajectories. Similarly, a close examination
of histological samples after anti-GFP immunohistochemistry
revealed that although the number was small, the axons of the
cTRNs could be traced from the cell bodies in the interme-
diate/deep layers of the right SC to their target areas. Axons
and terminals could be observed not only in the left medial
pontine reticular formation, the injection site of theNeuRet-TRE-
EGFP.eTeNT, but also in several nuclei in the mesodiencephalic
junction, pons, and medulla, which are targets of the ascend-
ing and descending collaterals of tectoreticular neurons (Grantyn
and Grantyn, 1982; Huerta and Harting, 1982) (Figure 6). The
possibility cannot be excluded that NeuRet-TRE-EGFP.eTeNT
had diffused to the right side of the pontine reticular formation
from the injection site, and some of these axons and termi-
nals belonged to ipsilaterally projecting tectoreticular neurons.
However, this should be a minor occurrence. In fact, the GFP-
positive neurons were found exclusively in the caudal and lateral
SC, where the cTRNs are located (Figure 5A), despite the fact
that injection of AAV2-CMV-rtTAV16 included more medial
parts of the SC (Figure 5B). If NeuRet-TRE-EGFP.eTeNT dif-
fused to the right side, the GFP-positive cells should have been
found also in more medial and rostral part of the SC where the
uncrossed tectoreticular neurons are primarily located (Redgrave
et al., 1990), Furthermore, the behavioral effects were clearly
those expected from the impairment of cTRNs. In the previous
reports (Grantyn and Grantyn, 1982; Isa and Sasaki, 2002), the
pontine projection of the cTRNs was described as almost exclu-
sively contralateral. The present report suggests there may be
species differences in this regard between rodents and carnivores.
As eTeNT was fused with EGFP, it should be transported to the
axon terminals in these areas. These results indicate that synap-
tic transmission to these targets was also blocked, and that the
behavioral effects cannot always be ascribed only to the block-
ade of transmission from the SC to the medial pontine reticular
formation, but also to the blockade of signal transmission to all
of the target nuclei. To conclude which connection was critical
for the observed behavioral effects, another technique, such as
optogenetic blockade of synaptic transmission at the nerve ter-
minal (Kaneda et al., 2011), will need to be combined with our
approach.
OTHER POSSIBLE USES OF THIS TECHNIQUE
The present results showed that the successful blockade of a
particular central pathway with the double viral vector tech-
nique could result in behavioral effects in mice. Using a sim-
ilar highly efficient retrograde gene transfer vector, some of
the authors of this article have produced the permanent abla-
tion of a central pathway by using it in combination with
an immunotoxin (Inoue et al., 2012). This may represent a
good approach for creating animal disease models. However,
one of the major advantages of the present technique is its
reversibility. Basically, this technique could be applicable to
any pathway in the brain. However, when we apply the cur-
rent technique to other pathways in the brain, it might be
necessary to use other serotypes of AAV, because efficiency
of transfection of each serotype could vary depending on the
target cell types (Blits et al., 2010; Jakovcevski et al., 2010;
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Markakis et al., 2010). The success of the current method was pri-
marily based on the following factors: (1) development of highly
efficient retrograde gene transfer using NeuRet; (2) very effi-
cient amplification of gene expression by the recently developed
Tet-ON sequence rtTAV16; and (3) very effective expression of
the humanized tetanus neurotoxin eTeNT. Replacing eTeNT with
other functional proteins, such as light-sensitive opsins for opto-
genetic control of neural activity (for reviews see Yizhar et al.,
2011; Tye and Disseroth, 2012), may open up a novel direction
for neural circuit analysis.
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